Allergic bronchopulmonary aspergillosis

Proceedings of the American Thoracic Society

Volumn 7, Issue 3, 2010, Pages 237-244

  Patterson, Karen ^a   Strek, Mary E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

ABPA; Allergic bronchopulmonary aspergillosis; Aspergillus; Asthma; Cystic fibrosis

Indexed keywords

AMPHOTERICIN B; BUDESONIDE; CORTICOSTEROID; IMMUNOGLOBULIN E; ITRACONAZOLE; METHYLPREDNISOLONE; OMALIZUMAB; PLACEBO; PREDNISOLONE; PREDNISONE; PYRROLE DERIVATIVE; VORICONAZOLE; ANTIFUNGAL AGENT; GLUCOCORTICOID; MONOCLONAL ANTIBODY; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; EARLY DIAGNOSIS; EOSINOPHILIA; HUMAN; IMMUNOPATHOGENESIS; LUNG FUNCTION; REMISSION; REVIEW; SKIN TEST; T LYMPHOCYTE ACTIVATION; TH2 CELL; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; HELPER CELL; IMMUNOLOGY; LUNG FUNCTION TEST; LYMPHOCYTE ACTIVATION; PATHOPHYSIOLOGY; RADIOGRAPHY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; DISEASE SUSCEPTIBILITY; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; LYMPHOCYTE ACTIVATION; PYRIMIDINES; RESPIRATORY FUNCTION TESTS; T-LYMPHOCYTES, HELPER-INDUCER; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAZOLES;

EID: 77955487177     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.200908-086AL     Document Type: Review

References (79)

1. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999;50:303-316. (Pubitemid 29117069)
2. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805-826.
3. Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. Chest 2000;118:66-72.
4. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, Denning DW, Crameri R, Brody AS, Light M, Skov M, Maish W, Mastella G; Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37:S225-S264.
5. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001;76:930-938. (Pubitemid 32825915)
6. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002;121:1988-1999. (Pubitemid 34634424)
7. Tillie-Leblond I, Tonnel A-B. Allergic bronchopulmonary aspergillosis. Allergy 2005;60:1004-1013. (Pubitemid 40942754)
8. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonry aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009;10:37-42.
9. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006;27:615-626. (Pubitemid 43372538)
10. Banerjee B, Kurup V. Molecular biology of aspergillus allergens. Immunol Allergy Clin North Am 1998;18:601-618. (Pubitemid 28369710)
11. Murali PS, Greenberger PA, Kurup VP. Cytokines in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:681-694. (Pubitemid 28369715)
12. Knutsen AP, Chauhan B, Slavin RG. Cell-mediated immunity in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:575-599. (Pubitemid 28369709)
13. Wark PAB, Saltos N, Simpson J, Slater S, Hensley MJ, Gibson PG. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000;16:1095-1101. (Pubitemid 32148124)
14. Kurup VP, Kumar A. Immunodiagnosis of aspergillosis. Clin Microbiol Rev 1991;4:439-456. (Pubitemid 21920408)
15. Shah A, Kala J, Sahay S, Panjabi C. Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 2008;101:363-369.
16. Varkey B. Allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:479-501.
17. Riscili BP, Wood KL. Noninvasive pulmonary aspergillus infections. Clin Chest Med 2009;30:315-335.
18. Shah A, Panchal N, Agarwal AK. Concomitant allergic bronchopulmonary aspergillosis and allergic aspergillus sinusitis: a review of an uncommon association. Clin Exp Allergy 2001;31:1896-1905. (Pubitemid 34014736)
19. Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses 2007;51:83-85.
20. Boz AB, Celmeli F, Arslan AG, Cilli A, Ogus C, Ozdemir T. A case of allergic bronchopulmonary aspergillosis following active pulmonary tuberculosis. Pediatr Pulmonol 2009;44:86-89.
21. Judson MA. Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. Chest 2009;135:1358-1359.
22. Novey HS. Epidemiology of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:641-653. (Pubitemid 28369712)
23. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier J-F, Vandenplas O. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001; 119:762-767. (Pubitemid 32197645)
24. Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Chest 1984;86:773-778. (Pubitemid 15217657)
25. Knutsen AP, Bellone C, Kauffman H. Immunopathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis. J Cyst Fibros 2002;1:76-89.
26. Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009;47:S331-S337.
27. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2001;110:685-692. (Pubitemid 35423169)
28. Kradin RL, Mark EJ. The pathology of pulmonary disorders due to aspergillus spp. Arch Pathol Lab Med 2008;132:606-614. (Pubitemid 351489614)
29. Kumar R. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Chest 2003;124:890-892. (Pubitemid 37123305)
30. Patterson R. Allergic bronchopulmonary aspergillosis: a historical perspective. Immunol Allergy Clin North Am 1998;18:471-478. (Pubitemid 28369703)
31. Agarwal R, Srinivas R, Aggarwal AN, Saxena AK. Pulmonary masses in allergic bronchopulmonary aspergillosis: mechanistic explanations. Respir Care 2008;53:1744-1748.
32. Lynch DA. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol Clin North Am 1998;36:129-142. (Pubitemid 28079679)
33. Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, Müller NL. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR 1999;173:937-942. (Pubitemid 29451289)
34. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India. Chest 2006;130:442-448. (Pubitemid 44267011)
35. Angus RM, Davies M-L, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994;49:586-589. (Pubitemid 24203164)
36. Martinez S, Heyneman LE, McAdams HP, Rossi SE, Restrepo CS, Eraso A. Mucoid impactions: finger-in-glove sign and other CT and radiographic features. Radiographics 2008;28:1369-1382.
37. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis. Chest 2007;132:1183-1190. (Pubitemid 47620991)
38. Hartl D, Buckland KF, Hogaboam CM. Chemokines in allergic aspergillosis - from animal models to human lung diseases. Inflamm Allergy Drug Targets 2006;5:219-228. (Pubitemid 44941932)
39. Agarwal R, Singh N, Gupta D. Pulmonary hypertension as a presenting manifestation of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 2009;51:37-40.
40. Nichols D, Dopico GA, Braun S, Imbeau S, Peters ME, Rankin J. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 1979;67:631-637. (Pubitemid 10249303)
41. Kauffman HF, Tomee JFC. Inflammatory cells and airway defense against aspergillus fumigatus. Immunol Allergy Clin North Am 1998;18:619-640. (Pubitemid 28369711)
42. Bosken CH, Myers JL, Greenberger PA, Katzenstein AA. Pathologic features of allergic bronchopumonary aspergillosis. Am J Surg Pathol 1988;12:216-222. (Pubitemid 18085206)
43. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-414. (Pubitemid 8078948)
44. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991;117:138-142.
45. de Oliveira E, Giavina-Bianchi P, Fonseca LAM, Francxa AT, Kalil J. Allergic bronchopulmonary aspergillosis' diagnosis remains a challenge. Respir Med 2007;101:2352-2357. (Pubitemid 47471403)
46. Sarma PU, Banerjee B, Bir N, Kurup V. Immunodiagnosis of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:525-547. (Pubitemid 28369707)
47. Patterson R, Greenberger PA, Halwig M, Liotta JL, Roberts M. Allergic bronchopulmonary aspirgillosis: natural history and classification of early diagnosis by serologic and roentgenographic studies. Arch Intern Med 1986;146:916-918. (Pubitemid 16116672)
48. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982;96:286-291. (Pubitemid 12187503)
49. Rajkumar DP. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. J Asthma 2002;39:473-477.
50. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Eur Respir J 2000;16:464-471.
51. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by fusarium vasinfectum. Am J Respir Crit Care Med 1995;152:1379-1381.
52. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984;74:68-71. (Pubitemid 14093028)
53. Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 1994;49:1002-1005. (Pubitemid 24315993)
54. Fink JN. Therapy of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998;18:655-660. (Pubitemid 28369713)
55. Sethi GR, Singhal KK. Pulmonary diseases and corticosteroids. Indian J Pediatr 2008;75:1045-1056.
56. Thomson JM, Wesley A, Byrnes CA, Nixon GM. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol 2006;41:164-170. (Pubitemid 43165446)
57. Imbeault B, Cormier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 1993;103:1614-1617. (Pubitemid 23145638)
58. Laoudi Y, Paolini J-B, Grimfed A, Just J. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA. Eur Respir J 2008;31:908-909.
59. Report to the Research Committee of the British Thoracic Association. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Br J Dis Chest 1979;73:349-356.
60. Ganassini A, Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med 1995;89:143-145.
61. Bodey GP, Glann AS. Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis. Chest 1993;103:299-301. (Pubitemid 23027286)
62. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. CID 2008;46:327-360. (Pubitemid 351265310)
63. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100:813-819.
64. Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 1995;107:883.
65. Salez F, Brichet A, Desurmont S, Grosbois J-M, Wallaert B, Tonnel A-B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-1668. (Pubitemid 30012710)
66. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, Bamberger DM, Weinmann AJ, Tuazon CU, Judson MA, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-762. (Pubitemid 30151919)
67. Wark PAB, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Simpson JL, McElduff P, Gibson PG. Anti-inflammatory effect of itraconazole in stable allergic bronchopumonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952-957. (Pubitemid 36570853)
68. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest 1999;115:364-370.
69. Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 2002;57:723-728. (Pubitemid 34836841)
70. Camuset J, Nunes H, Dombret M-C, Bergeron A, Henno P, Philippe B, Dauriat G, Mangiapan G, Rabbat A, Cadranel J. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocomprised patients. Chest 2007;131:1435-1441. (Pubitemid 46762349)
71. Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J Asthma 2007;44:891-895.
72. Mulliez P, Croxo C, Roy-Saint Georges F, Darras A. Aspergillose broncho-pulmonaire allergique traitée par voriconazole. Rev Mal Respir 2006;23:93-94.
73. Glackin L, Leen G, Elnazir B, Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir Med J 2009;102:29.
74. Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med 2009;360:2328-2339.
75. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008;43:1249-1251.
76. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007;62:276-277. (Pubitemid 46579813)
77. FDA Safety Notice. FDA issues early communication concerning safety of asthma drug Xolair. MD Consult July 17, 2009.
78. Kagen SL, Kurup VP, Sohnie PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983;71:389-393. (Pubitemid 13124946)
79. Hinson KFW, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis. Thorax 1952;7:317-333.